Author Ewa Haładyj
ORIGINAL PAPER
IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
Piotr Wojdasiewicz, Anna Wajda, Ewa Haładyj, Katarzyna Romanowska-Próchnicka, Anna Felis-Giemza, Jolanta Nałęcz-Janik, Marcela Walczyk, Marzena Olesińska, Beata Tarnacka, Agnieszka Paradowska-Gorycka
Reumatologia 2019;57(3):145–150
REVIEW PAPER
Antimalarials – are they effective and safe in rheumatic diseases?
Reumatologia 2018;56(3):164–173
REVIEW PAPER
Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
Reumatologia 2016;54(4):187–195
SHORT COMMUNICATION
Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases
Reumatologia 2016;54(3):146–149
EDITORIAL ARTICLE
Repeat renal biopsy in lupus nephritis – unnecessary harm and risk of complications or important diagnostic tool with clinical consequences?
Reumatologia 2016;54(2):49–50
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.